HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

BACKGROUND: Hepatitis B virus (HBV) genotypes can influence treatment outcome in HBV-monoinfected and human immunodeficiency virus (HIV)/HBV-coinfected patients. Tenofovir disoproxil fumarate (TDF) plays a pivotal role in antiretroviral therapy (ART) of HIV/HBV-coinfected patients. The influence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bihl, Florian, Martinetti, Gladys, Wandeler, Gilles, Weber, Rainer, Ledergeber, Bruno, Calmy, Alexandra, Battegay, Manuel, Cavassini, Matthias, Vernazza, Pietro, Caminada, Anna-Paola, Rickenbach, Martin, Bernasconi, Enos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495698/
https://www.ncbi.nlm.nih.gov/pubmed/26152237
http://dx.doi.org/10.1186/s12876-015-0308-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495698/
https://www.ncbi.nlm.nih.gov/pubmed/26152237
http://dx.doi.org/10.1186/s12876-015-0308-0

Ejemplares similares